Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Formulation of buprenorphine for sublingual use in neonates.
Anagnostis EA, Sadaka RE, Sailor LA, Moody DE, Dysart KC, Kraft WK. Anagnostis EA, et al. Among authors: kraft wk. J Pediatr Pharmacol Ther. 2011 Oct;16(4):281-4. doi: 10.5863/1551-6776-16.4.281. J Pediatr Pharmacol Ther. 2011. PMID: 22768012 Free PMC article.
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
Kraft WK, Adeniyi-Jones SC, Chervoneva I, Greenspan JS, Abatemarco D, Kaltenbach K, Ehrlich ME. Kraft WK, et al. N Engl J Med. 2017 Jun 15;376(24):2341-2348. doi: 10.1056/NEJMoa1614835. Epub 2017 May 4. N Engl J Med. 2017. PMID: 28468518 Free PMC article. Clinical Trial.
Buprenorphine for the Neonatal Abstinence Syndrome.
Kraft WK, Adeniyi-Jones SC, Ehrlich ME. Kraft WK, et al. N Engl J Med. 2017 Sep 7;377(10):997-998. doi: 10.1056/NEJMc1709121. N Engl J Med. 2017. PMID: 28877016 Free PMC article. No abstract available.
Buprenorphine in Neonatal Abstinence Syndrome.
Kraft WK. Kraft WK. Clin Pharmacol Ther. 2018 Jan;103(1):112-119. doi: 10.1002/cpt.930. Epub 2017 Nov 28. Clin Pharmacol Ther. 2018. PMID: 29105752 Free PMC article. Review.
105 results